Journal of Bioequivalence & Bioavailability

Editorial Note for Journal of Bioequivalence & Bioavailability

Fritz Sorgel^* Director, Institute of Biomedical and Pharmaceutical Research, Germany
^*Correspondence: Fritz Sorgel, Director, Institute of Biomedical and Pharmaceutical Research, Germany, Email:

Received: 06-Jul-2020 Published: 23-Jul-2020, DOI: 10.35248/0975-0851.20.12.397

Editorial

Without continual development and progress, such words as advancement, accomplishment, and success have no importance. Journal of Journal of Bioequivalence & Bioavailability was founded by Prof. Dr. Hanan Awad Alkozi in 2009 (ISSN: 0975-0851) is growing continuously. It is our pleasure to announce that during year 2019, all issues of volume 11 were published online on time and the print issues were also brought out and dispatched within 30 days of publishing the issue online.

Journal of Bioequivalence & Bioavailability during this year also brought out 10th World Congress on Bioavailability and Bioequivalence conference proceedings, which consisted of ~ 50 abstracts.

All published articles of this journal are included in the indexing and abstracting coverage of CAS Source Index (CASSI), Index Copernicus, Google Scholar, Sherpa Romeo, Academic Journals Database, Open J Gate, Genamics JournalSeek, Academic Keys, JournalTOCs, China National Knowledge Infrastructure (CNKI), CiteFactor, Scimago, Ulrich's Periodicals Directory, Electronic Journals Library, RefSeek, Hamdard University, EBSCO A-Z, OCLC- WorldCat, SWB online catalog, Virtual Library of Biology (vifabio), Publons, MIAR, University Grants Commission and Geneva Foundation for Medical Education and Research.

During the calendar year of 2019, JBB received a total of 9 manuscript, out of which 3 articles (30%) were rejected in the preliminary screening due to plagiarism or being out of the format and peer review process. During 2019 around 6 articles were subjected for publication after they are accepted in the peer review process. In the 2 issues of Volume 11 published during the year 2019, a total of 6 articles were published (at an average of 1 articles per issue) of which, articles were published from authors all around the world. Globally articles have been accessed by the research scientists and also cited.

Journal of Bioequivalence & Bioavailability also announces its new association with Longdom group for Archiving, Journal maintenance, financial purpose and support. However the journal will be running its original website https://www.longdom.org/bioequivalence-bioavailability.html parallel for Editorial and review work process so as to maintain its highest standard of scientific work.

I take this opportunity to acknowledge the contribution of Editor-in-Chief: Michael Retsky (USA), Yulong Yin (China), Sinerik Ayrapetyan (Armenia) and Executive Editors: Huixiao Hong (USA) during the final editing of articles published and the support rendered by the editorial assistants in bringing out issues of JBB in time. I would also like to express my gratitude to all the authors, reviewers, the publisher, the advisory and the editorial board of JBB, the office bearers for their support in bringing out yet another volume of JBB and look forward to their unrelenting support to bring out the Volume 12 of JBB in scheduled time.